Position history for FMR LLC's holdings in LEXICON PHARMACEUTICALS INC
FMR LLC holds 45.1M shares of LXRX (LEXICON PHARMACEUTICALS INC), worth $70.3M as of 2026-Q1. The position was increased (+19.1% shares). LXRX represents 0.0% of FMR LLC's portfolio.
Current Value
$70.3M
Current Shares
45.1M
Total Value Change
+$31.9M
Total Shares Change
-6.9M
Other major holders of LXRX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, FIRST MANHATTAN CO. LLC., BlackRock Finance, Inc., D. E. Shaw & Co., Inc.
Increased |
| 45.1M |
+19.1% |
| $70.3M |
| 0.0% |
| $1.61 |
35 |
| 2025-Q4 | Decreased | 37.8M | -2.2% | $43.5M | 0.0% | $1.15 | 0 |
| 2025-Q3 | Increased | 38.7M | +1.4% | $52.2M | 0.0% | $1.39 | 30 |
| 2025-Q2 | Increased | 38.1M | +10.4% | $36.1M | 0.0% | $0.82 | 32 |
| 2025-Q1 | Decreased | 34.5M | -33.5% | $15.9M | 0.0% | $0.57 | 0 |
| 2024-Q4 | New | 52M | - | $38.4M | 0.0% | $0.72 | 40 |